IL224463A - Peptide radiotracer compositions - Google Patents

Peptide radiotracer compositions

Info

Publication number
IL224463A
IL224463A IL224463A IL22446313A IL224463A IL 224463 A IL224463 A IL 224463A IL 224463 A IL224463 A IL 224463A IL 22446313 A IL22446313 A IL 22446313A IL 224463 A IL224463 A IL 224463A
Authority
IL
Israel
Prior art keywords
gly
peptide
cmbp
met binding
cyclic peptide
Prior art date
Application number
IL224463A
Other languages
English (en)
Hebrew (he)
Original Assignee
Ge Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare Ltd filed Critical Ge Healthcare Ltd
Publication of IL224463A publication Critical patent/IL224463A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nuclear Medicine (AREA)
IL224463A 2010-08-18 2013-01-29 Peptide radiotracer compositions IL224463A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1013808.9A GB201013808D0 (en) 2010-08-18 2010-08-18 Peptide radiotracer compositions
PCT/EP2011/063890 WO2012022676A1 (en) 2010-08-18 2011-08-11 Peptide radiotracer compositions

Publications (1)

Publication Number Publication Date
IL224463A true IL224463A (en) 2016-05-31

Family

ID=42938098

Family Applications (1)

Application Number Title Priority Date Filing Date
IL224463A IL224463A (en) 2010-08-18 2013-01-29 Peptide radiotracer compositions

Country Status (19)

Country Link
US (1) US9533059B2 (cg-RX-API-DMAC7.html)
EP (1) EP2605802B1 (cg-RX-API-DMAC7.html)
JP (1) JP6014592B2 (cg-RX-API-DMAC7.html)
KR (1) KR101853993B1 (cg-RX-API-DMAC7.html)
CN (1) CN103153350B (cg-RX-API-DMAC7.html)
AU (1) AU2011290856B2 (cg-RX-API-DMAC7.html)
BR (1) BR112013003469A2 (cg-RX-API-DMAC7.html)
CA (1) CA2807491C (cg-RX-API-DMAC7.html)
CL (1) CL2013000483A1 (cg-RX-API-DMAC7.html)
ES (1) ES2626410T3 (cg-RX-API-DMAC7.html)
GB (1) GB201013808D0 (cg-RX-API-DMAC7.html)
IL (1) IL224463A (cg-RX-API-DMAC7.html)
MX (1) MX348733B (cg-RX-API-DMAC7.html)
MY (1) MY163136A (cg-RX-API-DMAC7.html)
NZ (1) NZ606466A (cg-RX-API-DMAC7.html)
PH (1) PH12013500270A1 (cg-RX-API-DMAC7.html)
RU (1) RU2594167C2 (cg-RX-API-DMAC7.html)
SG (1) SG187878A1 (cg-RX-API-DMAC7.html)
WO (1) WO2012022676A1 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201103696D0 (en) * 2011-03-04 2011-04-20 Ge Healthcare Ltd Technetium labelled peptides
GB201121914D0 (en) * 2011-12-20 2012-02-01 Ge Healthcare Ltd Method for patient selection
GB201209082D0 (en) * 2012-05-24 2012-07-04 Ge Healthcare Ltd Purification method
GB201221266D0 (en) * 2012-11-27 2013-01-09 Ge Healthcare Ltd Aldehyde compositions
GB201314936D0 (en) 2013-08-21 2013-10-02 Ge Healthcare Ltd Radiolabelling method
GB201322451D0 (en) * 2013-12-18 2014-02-05 Ge Healthcare Ltd Purification method and compositions
GB201322456D0 (en) * 2013-12-18 2014-02-05 Ge Healthcare Ltd Radiotracer compositions and methods
WO2018022603A1 (en) * 2016-07-25 2018-02-01 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods of making 18f-labeled precursors and peptides, labeled c-met binding peptides, and methods of use thereof
GB201804835D0 (en) * 2018-03-26 2018-05-09 Ge Healthcare As Formulation and method of preparation
BR112021025124A2 (pt) 2019-06-14 2022-01-25 Edinburgh Molecular Imaging Ltd Composto, composição farmacêutica, kit para a preparação da composição farmacêutica, métodos de imagiologia e radioterapia do corpo de mamífero, de detecção, diagnóstico, prognóstico, previsão do resultado, cirurgia, estadiamento, tratamento, terapia, radioterapia, monitoramento do tratamento, monitoramento da progressão da doença e/ou monitoramento da terapia e de obtenção de uma imagiologia de locais e/ou tratamento de condições associadas à superexpressão ou localização de cmet in vivo, e, uso
GB201915206D0 (en) * 2019-10-21 2019-12-04 Ge Healthcare Ltd Use of cyclodextrins as a radiostabilizer
SE2050387A1 (en) * 2020-04-06 2021-10-07 Pvac Medical Tech Ltd Labelled substance and methods of detection of inflammation and infection using said substance
TW202305012A (zh) * 2021-03-22 2023-02-01 日商肽夢想股份有限公司 c-Met 蛋白質結合肽複合物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5961955A (en) * 1997-06-03 1999-10-05 Coulter Pharmaceutical, Inc. Radioprotectant for peptides labeled with radioisotope
AU2002357388A1 (en) 2001-12-27 2003-07-24 The United States Of America, As Represented By The Department Of Veterans Affairs Monoclonal antibody imaging and therapy of tumors that express met and bind hepatocyte growth factor
SI2949658T1 (sl) * 2003-03-03 2018-10-30 Dyax Corp. Peptidi, ki specifično vežejo HGF receptor (cMet) in njihove uporabe
GB0305704D0 (en) * 2003-03-13 2003-04-16 Amersham Plc Radiofluorination methods
GB0420344D0 (en) * 2004-09-14 2004-10-13 Amersham Plc Diagnostic compounds
JP2009542689A (ja) 2006-07-07 2009-12-03 ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ 選択的カスパーゼ阻害剤
GB0615211D0 (en) 2006-07-31 2006-09-06 Ge Healthcare Uk Ltd Asymmetric flouro-substituted polymethine dyes
RU2009112716A (ru) 2006-09-08 2010-10-20 Байер Шеринг Фарма Акциенгезельшафт (DE) Соединения и способы для агентов, меченых 18f
EP2099499A2 (en) 2006-12-13 2009-09-16 GE Healthcare AS Synthesis of a radiofluorinated peptide using microwave activation technology
US8216548B2 (en) * 2006-12-28 2012-07-10 Ge Healthcare As Radiofluorination methods
KR20090119966A (ko) 2007-03-01 2009-11-23 바이엘 쉐링 파마 악티엔게젤샤프트 진단 영상화제로서의 18ｆ 플루오로-벤조일 표지된 생물학적 활성 화합물, 벤조트리아졸-1-일옥시-벤조일, 2,5-디옥소-피롤리딘-1-일옥시)벤조일 및 트리메틸암모니오-벤조일 전구체
WO2008139207A2 (en) 2007-05-16 2008-11-20 Ge Healthcare As Labelled hgf binding peptides for imaging
GB0718967D0 (en) * 2007-09-28 2007-11-07 Ge Healthcare Ltd Peptide imaging agents
GB0718957D0 (en) * 2007-09-28 2007-11-07 Ge Healthcare Ltd Optical imaging agents
GB0716897D0 (en) 2007-08-30 2007-10-10 Univ Muenchen Tech Cancer imaging and treatment
GB0803477D0 (en) * 2008-02-26 2008-04-02 Ge Healthcare As Therapy selection method

Also Published As

Publication number Publication date
MY163136A (en) 2017-08-15
NZ606466A (en) 2014-11-28
AU2011290856B2 (en) 2014-12-04
RU2013105491A (ru) 2014-09-27
MX348733B (es) 2017-06-27
AU2011290856A1 (en) 2013-03-14
EP2605802B1 (en) 2017-04-26
MX2013001939A (es) 2013-03-18
US20130149241A1 (en) 2013-06-13
CN103153350A (zh) 2013-06-12
ES2626410T3 (es) 2017-07-25
SG187878A1 (en) 2013-03-28
CL2013000483A1 (es) 2014-03-07
CN103153350B (zh) 2016-06-29
RU2594167C2 (ru) 2016-08-10
US9533059B2 (en) 2017-01-03
JP2013540702A (ja) 2013-11-07
CA2807491C (en) 2019-06-04
GB201013808D0 (en) 2010-09-29
WO2012022676A1 (en) 2012-02-23
CA2807491A1 (en) 2012-02-23
EP2605802A1 (en) 2013-06-26
KR20130135242A (ko) 2013-12-10
PH12013500270A1 (en) 2013-04-01
BR112013003469A2 (pt) 2016-06-21
KR101853993B1 (ko) 2018-05-02
JP6014592B2 (ja) 2016-10-25

Similar Documents

Publication Publication Date Title
CA2807491C (en) F18 c-met binding cyclic peptide radiotracers and compositions thereof
US20220202965A1 (en) Radiotracer compositions and methods
US20130251632A1 (en) Apoptosis pet imaging agents
EP2680888A1 (en) Technetium labelled peptides
KR102061366B1 (ko) 환자 선정방법
EP3083526A1 (en) Purification method and compositions
HK1186119A (en) Peptide radiotracer compositions
HK1186119B (en) Peptide radiotracer compositions

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed